Provisional safe level for cannabidiol as a novel food – EFSA
The European Food Safety Authority, known as EFSA, has released a provisional safe intake level for cannabidiol, or CBD, when used as a novel food in Europe. This marks a significant step forward for the CBD industry in the European Union, where regulators have been working to establish clearer guidelines around CBD products sold for human consumption.
EFSA determined a temporary acceptable daily intake figure for CBD, which gives both consumers and manufacturers a reference point for how much CBD can be considered reasonably safe on a daily basis. This kind of regulatory benchmark is important because it helps shape the rules around how CBD products are labeled, dosed, and sold across EU member states.
For everyday consumers, this news means that European food safety officials are actively working to bring more structure and clarity to the CBD market. Rather than leaving people to guess about safe consumption levels, having an official provisional figure in place is a move toward greater transparency and consumer awareness.
It is worth noting that this provisional level is subject to change as more research becomes available, and it applies specifically to CBD as a novel food rather than as a medicine or supplement in every context. Anyone wanting to understand the full details of EFSA's findings and methodology should check the original source directly through the European Food Safety Authority's official publications.
